Chemoinformaics analysis of 1-Alpha-18O-1,25-dihydroxycholecalciferol
| Molecular Weight | 474.682 | nRot | 8 |
| Heavy Atom Molecular Weight | 428.314 | nRig | 20 |
| Exact Molecular Weight | 474.335 | nRing | 3 |
| Solubility: LogS | -4.375 | nHRing | 0 |
| Solubility: LogP | 3.276 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 83.1125 |
| nHD | 3 | BPOL | 48.7515 |
| QED | 0.418 |
| Synth | 4.81 |
| Natural Product Likeliness | 2.439 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.951 |
| Pgp-sub | 0.004 |
| HIA | 0.068 |
| CACO-2 | -4.75 |
| MDCK | 0.0000218 |
| BBB | 0.479 |
| PPB | 0.888261 |
| VDSS | 1.367 |
| FU | 0.0719163 |
| CYP1A2-inh | 0.035 |
| CYP1A2-sub | 0.105 |
| CYP2c19-inh | 0.114 |
| CYP2c19-sub | 0.572 |
| CYP2c9-inh | 0.436 |
| CYP2c9-sub | 0.21 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.096 |
| CYP3a4-inh | 0.423 |
| CYP3a4-sub | 0.565 |
| CL | 2.046 |
| T12 | 0.134 |
| hERG | 0.043 |
| Ames | 0.039 |
| ROA | 0.39 |
| SkinSen | 0.447 |
| Carcinogencity | 0.285 |
| EI | 0.012 |
| Respiratory | 0.872 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.802106 |